These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 8483320)
1. Characterization of acute myeloid leukemia (AML) coexpressing lymphoid markers: different biologic features between T-cell antigen positive and B-cell antigen positive AML. Tien HF; Wang CH; Chen YC; Shen MC; Lin DT; Lin KH Leukemia; 1993 May; 7(5):688-95. PubMed ID: 8483320 [TBL] [Abstract][Full Text] [Related]
2. Multiparameter analysis of acute mixed lineage leukemia: correlation of a B/myeloid immunophenotype and immunoglobulin and T-cell receptor gene rearrangements with the presence of the Philadelphia chromosome translocation in acute leukemias with myeloid morphology. Saikevych IA; Kerrigan DP; McConnell TS; Head DR; Appelbaum FR; Willman CL Leukemia; 1991 May; 5(5):373-82. PubMed ID: 2033959 [TBL] [Abstract][Full Text] [Related]
3. Characterization of Philadelphia-chromosome-positive acute leukemia by clinical, immunocytochemical, and gene analysis. Tien HF; Wang CH; Chuang SM; Lee FY; Liu MC; Chen YC; Shen MC; Lin DT; Lin KH; Lin KS Leukemia; 1992 Sep; 6(9):907-14. PubMed ID: 1325582 [TBL] [Abstract][Full Text] [Related]
5. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases. Janossy G; Coustan-Smith E; Campana D Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463 [TBL] [Abstract][Full Text] [Related]
6. Comparison between immunogenotypic findings in de novo AML and AML post MDS. Ohyashiki JH; Ohyashiki K; Kawakubo K; Fujimura T; Shimamoto T; Nakazawa S; Kimura N; Toyama K Leukemia; 1993 Nov; 7(11):1747-51. PubMed ID: 7694003 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of cell marker analysis in de novo acute myeloid leukemia. Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393 [TBL] [Abstract][Full Text] [Related]
10. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease. Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155 [TBL] [Abstract][Full Text] [Related]
13. Mixed phenotype acute leukemia with t(11;19)(q23;p13.3)/ MLL-MLLT1(ENL), B/T-lymphoid type: A first case report. Naghashpour M; Lancet J; Moscinski L; Zhang L Am J Hematol; 2010 Jun; 85(6):451-4. PubMed ID: 20513125 [TBL] [Abstract][Full Text] [Related]
14. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood. Wiersma SR; Ortega J; Sobel E; Weinberg KI N Engl J Med; 1991 Mar; 324(12):800-8. PubMed ID: 1997852 [TBL] [Abstract][Full Text] [Related]
15. Definition of acute biphenotypic leukemia. Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085 [TBL] [Abstract][Full Text] [Related]
16. Configuration of immunoglobulin and T cell receptor beta and gamma genes in acute myeloid leukaemia: pitfalls in the analysis of 40 cases. Parreira L; Carvalho C; Moura H; Melo A; Santos P; Guimarães JE; Parreira A J Clin Pathol; 1992 Mar; 45(3):193-200. PubMed ID: 1372916 [TBL] [Abstract][Full Text] [Related]
17. Lineage determination of CD7+ CD5- CD2- and CD7+ CD5+ CD2- lymphoblasts: studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3 epsilon, and CD3 delta. Yoneda N; Tatsumi E; Teshigawara K; Nagata S; Nagano T; Kishimoto Y; Kimura T; Yasunaga K; Yamaguchi N Am J Hematol; 1994 Apr; 45(4):310-20. PubMed ID: 7513945 [TBL] [Abstract][Full Text] [Related]
18. Different stages of B cell differentiation in non-T acute lymphoblastic leukemia. Foa R; Migone N; Saitta M; Fierro MT; Giubellino MC; Lusso P; Cordero di Montezemolo L; Miniero R; Lauria F J Clin Invest; 1984 Nov; 74(5):1756-63. PubMed ID: 6438157 [TBL] [Abstract][Full Text] [Related]